Objectives. To assess the natural history of interstitial cystitis in the p
resence of sulfated polysaccharide treatment.
Methods. This was a longitudinal study of 274 patients. Questionnaires were
administered at first visit to obtain information on demographic character
istics, medical history, other risk factors, and type and severity of sympt
oms. Follow-up questionnaires were administered at subsequent visits to mea
sure symptom progress. Patient status over time was measured for three symp
toms: pain, urgency, and nocturia. Changes in symptom and severity were ass
essed at 6, 12, and 24 months on treatment. Comparisons of symptom change f
rom baseline to 6 and 12 months were assessed for different characteristics
among patients with the most severe symptoms.
Results. After 1 year of treatment, a decrease of two or more points in sym
ptom score was observed for 33.5% of all patients for pain and 35.4% for ur
gency. Among patients with the most severe symptoms, a decrease of two or m
ore points was observed in more than 54% for pain and urgency; 55.7% experi
enced remission to the moderate and mild level (49.2% and 6.5%, respectivel
y). There was no appreciable decrease in nocturia at any severity level. Wi
th the exception of feeling heavy and experiencing dull pain at baseline, p
atients who did not report a specific type of pain improved more than those
who did.
Conclusions. The results of this study suggest that treatment with sulfated
polysaccharides can help alleviate the symptoms of patients suffering from
the most severe stages of interstitial cystitis. UROLOGY 53: 1155-1159, 19
99. (C) 1999, Elsevier Science Inc. All rights reserved.